Here’s what to know about the 2024-2025 vaccines — what’s available, how the updated versions are tested, how well each protects you, side effects and other safety information, the best time to get ...

The menstrual irregularities experienced by unvaccinated and unexposed women were consistent with those experienced by the ...

The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled ...

Sanofi SNY announced that the FDA has granted a Fast Track designation to two combination vaccine candidates to prevent ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

The following is a summary of “COVID-19 vaccination and cerebral small vessel disease progression - A prospective cohort ...

Explore groundbreaking research linking SARS-CoV-2 spike protein accumulation to long-lasting brain effects in long COVID.

SARS-CoV-2 spike protein lingers in brain tissues for years. While vaccines cut accumulation by 50%, risks remain. Read more.

A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms.

Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution ...